Roy lab (@ProfAvikRoy) header
Roy lab (@ProfAvikRoy) profile picture

CSO Simmaron Research ; MIDD member, @RedefiningMECFS; CoFounder/Sci. Director of SIMMPHARM: Professor (adj) @UWM; Neurobio; ME/CFS; Drug design and development

Milwaukee, WI
Joined October 2019
Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)Photo by Roy lab (@ProfAvikRoy)
Take a scroll break and listen to the next step in our Rapamycin treatment trial for #MECFS and #LongCovid. Dr. Gunnar Gottschalk provides a look forward as we start gearing up for a double blind placebo trial. #GivingTuesday
5
21
504
Roy lab retweeted
Appreciate Simmaron highlighting this work. There’s a real need for more rigorous research in ME/CFS, POTS, and Long COVID, and we’re proud to help build the evidence base around Rapamycin.
2
7
179
Roy lab retweeted
Rapamycin may tie these three converging threads together in ME/CFS. @RedefiningMECFS @UWM @SpringerNature @ggottschalkPhD The link of our newest article link.springer.com/article/10…
14
1
43
2,776
Watch! Dr. Avik Roy & Dr. Gunnar Gottschalk of @RedefiningMECFS share how six years of work on the molecular mechanisms of #MECFS has led to one of the only ongoing clinical trials specifically designed around a defined biological target. youtu.be/OMmjcTKxivU #MEAwarenessHour
1
15
2
30
2,731
Roy lab retweeted
The #UWM community extends its heartfelt sympathies and condolences to the @MarquetteU lacrosse team and the entire Marquette community for the tragic loss of its two student-athletes. We are keeping you in our thoughts.
1
1
53
2,140
🚨 Big news! Simmaron Research wins our latest Solve #MECFS Catalyst Award! We’re proud to provide funding for the Low-Dose Rapamycin trial. Congrats to @ggottschalkPhD @AvikRoy74969264 & the whole @RedefiningMECFS team! 💡 Learn more:ow.ly/WSsW50WavSb
2
13
25
1,050
Congrats to the entire team @RedefiningMECFS and @AvikRoy74969264 on this breakthrough paper describing a disease-relevant model of PEM link.springer.com/content/pd… Here, we show that chronic mTOR activation disrupts autophagy function, leading to PEM and the production of IL-6 and RANTES via STAT3 phosphorylation!
13
60
14
219
38,805
Exciting news! We have formed a strategic partnership with @AgelessRx, a leader in decentralized clinical trial execution, to expand our #rapamycin treatment trial for #ME and #LongCovid in the new year. Read more: simmaronresearch.com/blog/si… 1/2
5
23
2
84
6,915
Only 2 weeks until #GivingTuesday! This marks 9 months of our #rapamycin trial in #MECFS and #LongCovid. Phase 1 is on its way to results on symptoms and biomarkers. Donate now to this groundbreaking work! #ME #POTS #PEM bit.ly/Simmaron
4
13
672
There's also another fascinating trial being led by @AvikRoy74969264 at @RedefiningMECFS of low-dose rapamycin in people with ME/CFS to see whether it can improve mitochondrial function and quality of life by stimulating cellular recycling and repair.
1
8
51
1,619
We're proud to be part of Milwaukee Institute for Drug Discovery & grateful to partner with them on the science of our #rapamycin trial. #ME #LongCovid patients need this kind of collaboration to develop treatments! Donate to this work! #MIDD @UMW #MECFS bit.ly/Simmaron
1
2
8
795
We continue to make good progress on the Rapamycin trial. I’m so thankful to the participants. You can’t do this kind of research without their guidance and participation. The quote below is one of many. Not everyone will respond. This isn’t my first rodeo. Our goal is biomarker directed clinical trials—like we are doing now. Understanding responders to therapy will help the field of #MECFS and #LongCovid. Thanks to our collaborators @GrachStephanie @CornellMECFS @BatemanHorne David Kaufman MD, Bela Chheda MD, Dan Peterson MD and Jon Berner MD. “I am a responder to the rapamycin. I am not sure if the details are of any interest or maybe helpful to the research but I’ll include a few. The next day after taking my first dose, I noticed immediately I was able to retain twice the amount of water I usually do (I have a schedule of water and salt intake for POTS). For the next four days I incrementally felt this sensation of blood returning to my brain, kind of like when your arm falls asleep and it feels tingly when it “wakes up”. I was 100% bedbound before starting and now I can sit at my desk for 4 hours. I will be attempting more movement here shortly. The RELIEF in my brain is astronomical. My anhedonia and dissociation has hugely improved, I can feel some emotions again from my memories.” Thanks for your support of @RedefiningMECFS
13
36
8
194
13,583
Please check out Simmaron's newest publication here! Thank you to all of the patients and our supporters! doi.org/10.1177/117957352412… “Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway” @RedefiningMECFS @AvikRoy74969264 @PlzSolveCFS @NINDSdirector @NIH_NINDS
3
17
2
43
3,227
Who out there knew that inks used for permanent tattoos contain heavy metals, including mercury (red inks)? Before you got a tattoo? Do you really want this exposure? On top of microplastics, POPs and various xenobiotics? Here’s an easy (but worrying) read from Sci Am: scientificamerican.com/artic…
7
9
1
46
6,102
Huge congrats to Molly Drosen and Amy Reyes for taking 1st and 2nd place presenting their posters describing key mechanisms underlying ME/CFS at the UWM annual chemistry symposium! Great mentorship from Avik Roy!! @UWM @RedefiningMECFS @AvikRoy74969264
1
8
30
1,276